Calhoun Lesley Ann
Insider CIK 1730866 · GBT See Remarks · ALGS See Remarks · TNGX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2026-06-05 | 2026-06-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2026-06-05 | 2026-06-08 | 4,000 | — | $0 | 16,500 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2026-03-09 | 2026-03-11 | 37,485 | — | $0 | 37,485 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2025-07-16 | 2025-07-18 | 40,185 | — | $0 | 40,185 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 37,500 | — | $0 | 37,500 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2025-06-05 | 2025-06-09 | 6,250 | — | $0 | 12,500 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2025-02-28 | 2025-03-04 | 47,271 | — | $0 | 47,271 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-09-04 | 2024-09-06 | 10,880 | — | $0 | 10,880 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 37,500 | — | $0 | 37,500 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-06-05 | 2024-06-07 | 5,000 | $7.21 | $36.0K | 6,250 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2024-06-05 | 2024-06-07 | 6,250 | — | $0 | 11,250 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 308,940 | — | $0 | 308,940 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 18,750 | — | $0 | 18,750 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 74,998 | — | $0 | 74,998 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 51,833 | — | $0 | 51,833 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 26,250 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 105,000 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 176,237 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2023-09-08 | 2023-09-12 | 48,000 | — | $0 | 48,000 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2023-06-06 | 2023-06-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2023-03-15 | 2023-03-17 | 78,750 | — | $0 | 78,750 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-07-07 | 2022-07-11 | 52,500 | — | $0 | 52,500 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-02-04 | 2022-02-08 | 105,000 | — | $0 | 105,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-02-04 | 2022-02-08 | 26,250 | — | $0 | 26,250 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2020-12-01 | 2020-12-03 | 176,237 | — | $0 | 176,237 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-05-26 | 2020-05-28 | 2,700 | — | $0 | 900 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-05-26 | 2020-05-28 | 2,700 | $29.75 | $80.3K | 2,854 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-05-26 | 2020-05-28 | 2,700 | $70.10 | $189.3K | 154 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-05-18 | 2020-05-20 | 23,330 | — | $0 | 1,875 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-05-18 | 2020-05-20 | 23,330 | $74.67 | $1.74M | 154 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-05-18 | 2020-05-20 | 23,330 | $22.00 | $513.3K | 23,484 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-05-12 | 2020-05-13 | 2,992 | $78.38 | $234.5K | 154 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-05-11 | 2020-05-13 | 381 | $77.05 | $29.4K | 3,146 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-03-01 | 2020-03-04 | 300 | — | $0 | 600 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-03-01 | 2020-03-04 | 300 | — | $0 | 3,631 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2020-03-01 | 2020-03-04 | 104 | $63.96 | $6.7K | 3,527 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-02-03 | 2020-02-04 | 9,160 | — | $0 | 9,160 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-02-03 | 2020-02-04 | 14,610 | — | $0 | 14,610 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-02-01 | 2020-02-04 | 2,313 | — | $0 | 13,875 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-02-01 | 2020-02-04 | 750 | — | $0 | 3,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-02-01 | 2020-02-04 | 3,063 | — | $0 | 4,485 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2020-02-01 | 2020-02-04 | 1,154 | $65.26 | $75.3K | 3,331 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2020-01-31 | 2020-02-04 | 535 | $36.68 | $19.6K | 1,422 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2019-09-11 | 2019-09-13 | 2,765 | $54.36 | $150.3K | 887 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-09-01 | 2019-09-04 | 300 | — | $0 | 900 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-09-01 | 2019-09-04 | 300 | — | $0 | 3,756 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-09-01 | 2019-09-04 | 104 | $45.98 | $4.8K | 3,652 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-08-01 | 2019-08-05 | 750 | — | $0 | 3,750 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-08-01 | 2019-08-05 | 2,312 | — | $0 | 16,188 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-08-01 | 2019-08-05 | 3,062 | — | $0 | 4,516 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-08-01 | 2019-08-05 | 1,060 | $54.25 | $57.5K | 3,456 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2019-07-31 | 2019-08-05 | 226 | $36.68 | $8.3K | 1,454 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-03-01 | 2019-03-05 | 300 | — | $0 | 1,200 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-03-01 | 2019-03-05 | 104 | $53.48 | $5.6K | 1,228 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-03-01 | 2019-03-05 | 300 | — | $0 | 1,332 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2019-02-12 | 2019-02-14 | 354 | $50.45 | $17.9K | 1,032 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-02-01 | 2019-02-05 | 18,500 | — | $0 | 18,500 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-02-01 | 2019-02-05 | 13,500 | — | $0 | 13,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-02-01 | 2019-02-05 | 750 | — | $0 | 4,500 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-02-01 | 2019-02-05 | 307 | $48.44 | $14.9K | 1,477 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-02-01 | 2019-02-05 | 750 | — | $0 | 1,784 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2019-01-31 | 2019-02-14 | 354 | $36.68 | $13.0K | 1,386 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-09-04 | 2018-09-06 | 104 | $48.95 | $5.1K | 1,034 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-09-01 | 2018-09-06 | 300 | — | $0 | 1,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-09-01 | 2018-09-06 | 300 | — | $0 | 1,138 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-08-17 | 2018-08-20 | 300 | $49.19 | $14.8K | 838 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-08-16 | 2018-08-20 | 1,000 | — | $0 | 25,205 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-08-16 | 2018-08-20 | 500 | — | $0 | 26,205 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-08-16 | 2018-08-20 | 1,000 | $22.00 | $22.0K | 2,638 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-08-16 | 2018-08-20 | 1,500 | $50.01 | $75.0K | 1,138 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-08-16 | 2018-08-20 | 500 | $22.00 | $11.0K | 1,638 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-08-16 | 2018-08-20 | 204 | $49.97 | $10.2K | 1,138 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-08-01 | 2018-08-03 | 750 | — | $0 | 5,250 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-08-01 | 2018-08-03 | 750 | — | $0 | 1,138 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2018-07-31 | 2018-08-20 | 204 | $35.53 | $7.2K | 1,342 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-07-09 | 2018-07-10 | 2,295 | — | $0 | 26,705 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-07-09 | 2018-07-10 | 2,295 | $44.27 | $101.6K | 388 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-07-09 | 2018-07-10 | 2,295 | $22.00 | $50.5K | 2,683 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-07-06 | 2018-07-10 | 1,000 | — | $0 | 29,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-07-06 | 2018-07-10 | 1,000 | $22.00 | $22.0K | 1,388 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-07-06 | 2018-07-10 | 1,000 | $44.01 | $44.0K | 388 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-03-05 | 2018-03-05 | 99 | $60.35 | $6.0K | 388 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-03-01 | 2018-03-05 | 300 | — | $0 | 1,800 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-03-01 | 2018-03-05 | 300 | — | $0 | 487 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-02-01 | 2018-02-13 | 9,000 | — | $0 | 9,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-02-01 | 2018-02-13 | 6,000 | — | $0 | 6,000 | SEC↗ |